Exicure Stock (NASDAQ: XCUR) stock price, news, charts, stock research, profile.
Open | $0.490 |
Close | $0.501 |
Volume / Avg. | 6.709K / 217.831K |
Day Range | 0.490 - 0.510 |
52 Wk Range | 0.365 - 1.500 |
Market Cap | $4.367M |
P/E Ratio | 0.283 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 2.39% |
Days to Cover | 9.13 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Exicure (NASDAQ: XCUR) through any online brokerage.
Other companies in Exicure’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Exicure (NASDAQ: XCUR) was reported by Chardan Capital on Tuesday, August 16, 2022. The analyst firm set a price target for 2.00 expecting XCUR to rise to within 12 months (a possible 296.04% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Exicure (NASDAQ: XCUR) is $0.505 last updated May 3, 2024 at 9:01 AM EDT.
There are no upcoming dividends for Exicure.
Exicure’s Q1 earnings are confirmed for Friday, July 12, 2024.
There is no upcoming split for Exicure.
Exicure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.